Metformin in Intrahepatic Cholestasis of Pregnancy
Status:
Unknown status
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
This is a pilot study aimed at comparing the effect of metformin versus ursodeoxycholic acid
in women with intrahepatic cholestasis in pregnancy. The study will be conducted in three NHS
hospital sites, over an 18 month period.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Epsom and St Helier University Hospitals NHS Trust
Collaborators:
King's College Hospital NHS Trust Medway NHS Foundation Trust